ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2021

Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient.

Dandan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.